Other Drug-Induced Inflammatory Skin Reactions DOI

Chai Zi Teng,

Shashendra Aponso, Haur Yueh Lee

и другие.

Updates in clinical dermatology, Год журнала: 2022, Номер unknown, С. 191 - 202

Опубликована: Янв. 1, 2022

Язык: Английский

Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options DOI Creative Commons
Tejas P. Joshi, Madeleine Duvic

American Journal of Clinical Dermatology, Год журнала: 2021, Номер 23(1), С. 37 - 50

Опубликована: Сен. 8, 2021

Granuloma annulare (GA) is an inflammatory granulomatous skin disease that can be localized (localized GA) or disseminated (generalized GA), with patch, perforating, and subcutaneous subtypes being less common variants of this benign condition. Recently, new research has emerged further elucidates GA epidemiology etiopathogenesis; importantly, therapeutic options for have also been described, although there remains a paucity randomized controlled studies. In review, we summarize recent updates on etiopathogenesis offer updated review the currently reported in literature. We hope current galvanizes studies will turn help lead to recommendation evidence-based treatments GA.

Язык: Английский

Процитировано

95

Drug-induced sarcoidosis-like reactions DOI
Jelle Miedema, Hilario Nunès

Current Opinion in Pulmonary Medicine, Год журнала: 2021, Номер 27(5), С. 439 - 447

Опубликована: Июнь 28, 2021

Purpose of review Sarcoidosis is a complex granulomatous disease unknown cause. Several drug categories are able to induce systemic indistinguishable from sarcoidosis, known as drug-induced sarcoidosis-like reaction (DISR). This inflammation can resolve if the medication discontinued. In this review, we discuss recent literature on associated with DISR, possible pathophysiology, clinical features, and treatment. Recent findings Recently, increasing reports DISR have expanded list drugs eruption. Most reported be categorized combination antiretroviral therapy, tumor necrosis factor-α antagonist, interferons, immune checkpoint inhibitors, but other also published. The proposed mechanism enhancement aberrant response which results in granuloma formation. It currently not know whether represents separate entity or triggered ‘true’ sarcoidosis. As DISRs may cause minimal symptoms, treatment always necessary benefits continuing offending should weighed against symptoms organ dysfunction. Treatment involve immunosuppressive that used for sarcoidosis Summary article, insights DISR: categories, presentation, diagnosis, Additionally, mechanisms add our knowledge pathophysiology.

Язык: Английский

Процитировано

33

Successful Treatment of Refractory Generalized Granuloma Annulare with Upadacitinib DOI Creative Commons
Alexis Coican,

Abigail L. Meckley,

Nathan Sagasser

и другие.

Case Reports in Dermatological Medicine, Год журнала: 2024, Номер 2024(1)

Опубликована: Янв. 1, 2024

Granuloma annulare is a poorly understood dermatosis that, when generalized, can occur in up to 15 percent of patients. In these cases, treatment frustrating and experimental. We report case 60‐year‐old woman 41‐year‐old who demonstrated resolution recalcitrant, generalized granuloma (GA) following oral with upadacitinib. After showing little no response other various treatments, such as steroids, antibiotic regimens, systemic therapies, each patient was started on mg daily At 2 months, one had complete clearance all lesions while the experienced noticeable improvement. Within 4 reached total her lesions. These cases provide evidence therapeutic option that may shorten disease duration relief from cutaneous disease.

Язык: Английский

Процитировано

4

Systemic Janus kinase inhibitors in the management of granuloma annulare DOI
Scott Stratman, S. Abu Amara, Kathryn Tan

и другие.

Archives of Dermatological Research, Год журнала: 2025, Номер 317(1)

Опубликована: Апрель 29, 2025

Язык: Английский

Процитировано

0

Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features DOI

J Martel,

Hannah L. Hanania, Anisha B. Patel

и другие.

Human Pathology, Год журнала: 2023, Номер 140, С. 144 - 172

Опубликована: Май 2, 2023

Язык: Английский

Процитировано

1

Granuloma annulare and possible relation to purified protein derivative administration: a case report DOI Creative Commons
Ernest C. Lee,

Cheryl A. Steffen,

Minnerva E. Carroz

и другие.

Journal of Medical Case Reports, Год журнала: 2024, Номер 18(1)

Опубликована: Июнь 20, 2024

Abstract Background Granuloma annulare is a noninfectious inflammatory granulomatous skin disease characterized by an erythematous or colored plaque. The diagnosis of granuloma may be challenging owing to its diverse morphology. In such cases, correlation between the clinical findings and histologic are necessary. Case presentation We report case after purified protein derivative administration. A 56-year-old Caucasian female patient complained mildly pruritic rashes which started on both arms lower extremities, eventually spread thighs, left popliteal region, upper back, right abdominal area. About 6 weeks prior eruption rashes, had been given tuberculin test. Biopsy specimens revealed dermal histiocytes palisading around areas mucin degenerated collagen, confirming annulare. After treatment with 0.1% topical triamcinolone acetanide 500 mg oral metronidazole, patient’s lesions resolved. Discussion Relatively little known about annulare’s exact etiology. has four variations presenting as either localized, generalized, subcutaneous, perforating patch prognosis for varies according subtypes. Proposed causal mechanisms subcutaneous include physical trauma, infections, immunizations, insect bites, diabetes mellitus, alterations in cell-mediated immune responses. likely component. Clinically, confused many other diseases. Conclusion This was reported since it rare dermatologic pathological condition that can rash disorders. Although benign self-limited disease, definitive important rule out pathologies similar appearances, cancer human immunodeficiency virus (HIV) infection. Diagnostic confirmation best made through biopsy.

Язык: Английский

Процитировано

0

Dupilumab-Induced Granuloma Annulare: A Challenging Adverse Effect of Atopic Dermatitis Treatment DOI Creative Commons
Christeebella O. Akpala, Yueping Zhang, Giang Huong Nguyen

и другие.

Indian Journal of Dermatology, Год журнала: 2024, Номер unknown

Опубликована: Окт. 12, 2024

Язык: Английский

Процитировано

0

Treatment of generalized granuloma annulare with tildrakizumab DOI
Andrew Awad, Alexander Nirenberg, Rodney Sinclair

и другие.

Australasian Journal of Dermatology, Год журнала: 2022, Номер 63(3)

Опубликована: Май 2, 2022

Язык: Английский

Процитировано

2

Onset of Sarcoidosis in Patients on Biologic Therapy: A Systematic Review DOI
Yuliya Lytvyn, Asfandyar Mufti, Muskaan Sachdeva

и другие.

Journal of Cutaneous Medicine and Surgery, Год журнала: 2022, Номер 26(5), С. 512 - 513

Опубликована: Май 19, 2022

Язык: Английский

Процитировано

2

Granulomatöse Dermatosen DOI
Maria Kinberger, Hanna Bonnekoh,

Amrei Dilling

и другие.

Zeitschrift für Rheumatologie, Год журнала: 2022, Номер 81(7), С. 577 - 586

Опубликована: Июль 19, 2022

Процитировано

2